R J van Alphen
- Molecular Biology
- Oncology top 5%
- Pulmonary and Respiratory Medicine
- Pharmacology top 10%
- Pharmacology top 5%
- Co-authors
- Ron H.J. MathijssenKees NooterAlex SparreboomG. StoterJaco J. VerweijHenry BurgerFerry A.L.M. EskensErik A.C. Wiemer
- Topics
- Cancer therapeutics and mechanisms (3 papers)Neutropenia and Cancer Infections (2 papers)Colorectal Cancer Treatments and Studies (2 papers)
- Partner nations
- NetherlandsUnited States
In The Last Decade
R J van Alphen
6 papers receiving 840 citations
Hit Papers
Peers
Comparison fields: 5 of 83
- Molecular Biology 549
- Oncology 535
- Pulmonary and Respiratory Medicine 103
- Pharmacology 92
- Pharmacology 91
Countries citing papers authored by R J van Alphen
This map shows the geographic impact of R J van Alphen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R J van Alphen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R J van Alphen more than expected).
Fields of papers citing papers by R J van Alphen
This network shows the impact of papers produced by R J van Alphen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R J van Alphen. The network helps show where R J van Alphen may publish in the future.
Co-authorship network of co-authors of R J van Alphen
This figure shows the co-authorship network connecting the top 25 collaborators of R J van Alphen. A scholar is included among the top collaborators of R J van Alphen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R J van Alphen. R J van Alphen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 47 | |
| 2 | 1 | |
| 3 | 80 | |
| 4 | Clinical pharmacokinetics and metabolism of irinotecan (CPT-11).breakdown → | 626 |
| 5 | 9 | |
| 6 | Irinotecan (CPT-11) metabolism and disposition in cancer patients. | 97 |
About R J van Alphen
R J van Alphen is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology, having authored 6 papers that have together received 860 indexed citations. Recurring topics across this work include Cancer therapeutics and mechanisms (3 papers), Neutropenia and Cancer Infections (2 papers) and Colorectal Cancer Treatments and Studies (2 papers). The work is most often cited by research in Oncology (535 citations), Pharmacology (91 citations) and Molecular Biology (549 citations). R J van Alphen has collaborated with scholars based in Netherlands and United States. Frequent co-authors include Ron H.J. Mathijssen, Kees Nooter, Alex Sparreboom, G. Stoter, Jaco J. Verweij, Henry Burger, Ferry A.L.M. Eskens, Erik A.C. Wiemer, Peter de Bruijn and E. Brouwer. Their work appears in journals such as British Journal of Cancer, Annals of Oncology and European Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.